The TDap vaccine started to be given to pregnant women in 2011 and this is when fetal deaths started to outnumber infant deaths for the first time

The TDap vaccine started to be given to pregnant women in 2011 and this is when fetal deaths started to outnumber infant deaths for the first time. There has been a study showing that TDaP vaccine increases rate of miscarriage by 16.7% in the third trimester. And since it’s the third trimester it’s considered a fetal death.
Study: Adverse event reports after tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines in pregnant women.
RESULTS
The most frequent pregnancy-specific AE was spontaneous abortion in 22 (16.7%) reports. Injection site reactions were the most frequent non-pregnancy-specific AE found in 6 (4.5%) reports. One report with a major congenital anomaly (gastroschisis) was identified.

Study: Live virus vaccination near a pregnancy: flawed policies, tragic results.
Vaccination of women with live virus vaccines around conception has always been contraindicated by the Center for Disease Control and Prevention (CDC) and the vaccine manufacturer because of potential risks to the fetus. Nevertheless this dangerous practice occurs and is associated with maternal health problems and a very high incidence of early-onset autism in the children. Postpartum vaccination with live virus vaccines has been recommended by the CDC, and described as ‘convenient’ by the vaccine manufacturer. This ‘routine practice’ may lead to health and is also associated with many health and obstetrical problems in the recipient, and is frequently associated with autism in both current and future children. Re-vaccination often fails to produce immunity, the very reason for which it was recommended.

Medscape Medical News
Fetal Deaths Outnumber Infant Deaths for First Time in US
Fetal deaths after 20 weeks’ gestation have not declined in recent years, and starting in 2011, there were more fetal deaths than infant deaths in the United States, according to data from 2011 to 2013 published by the Centers for Disease Control and Prevention in a National Vital Statistics Report.
“Much of the public concern surrounding reproductive loss has focused on infant mortality, due in part to a lesser knowledge of the incidence, etiology, and prevention strategies for fetal mortality,” the authors write, calling for more research on the occurrence and causes of fetal death.

Fetal and Perinatal Mortality: United States, 2013
by Marian F. MacDorman, Ph.D., and Elizabeth C.W. Gregory, M.P.H., Division of Vital Statistics
Results—
A total of 23,595 fetal deaths at 20 weeks of gestation or  more  were  reported  in  the  United  States  in  2013.  The  U.S.  fetal  mortality rate was 5.96 fetal deaths at 20 weeks of gestation or more
per 1,000 live births and fetal deaths, not significantly different from the  rate  of  6.05  in  2012.  The  lack  of  decline  in  fetal  mortality  in  recent  years,  coupled  with  declines  in  infant  mortality,  meant  that
more fetal deaths than infant deaths occurred in the United States for 2011–2013 (although the rates were essentially the same). In 2013, the  fetal  mortality  rate  for  non-Hispanic  black  women  (10.53)  was
more than twice the rate for non-Hispanic white (4.88) and Asian or Pacific Islander (4.68) women. The rate for American Indian or Alaska Native  women  (6.22)  was  27%  higher,  and  the  rate  for  Hispanic
women (5.22) was 7% higher, than the rate for non-Hispanic white women.  Fetal  mortality  rates  were  highest  for  teenagers,  women  aged  35  and  over,  unmarried  women,  and  women  with  multiple  pregnancies.

U.S. has highest first-day infant mortality out of industrialized world, group reports
About 11,300 newborns die within 24 hours of their birth in the U.S. each year, 50 percent more first-day deaths than all other industrialized countries combined, the report’s authors stated.
The 14th annual State of the World’s Mothers report, put together by non-profit organization Save the Children, ranked 168 countries according to where the best places to be a mother would be. Criteria included child mortality, maternal mortality, the economic status of women, educational achievement and political representation of women.
Worldwide, the report found that 800 women die each day during pregnancy or childbirth, and 8,000 newborns die during the first month of life. Newborn deaths make up 43 percent of all deaths for children under five. Sixty percent of infant deaths occur during the first month of life.
The top five countries to be a mom were Finland, Sweden, Norway, Iceland and the Netherlands. The bottom five were Niger, Mali, Sierra Leone, Somalia and the Democratic Republic of the Congo.
Because of their high infant mortality rates, the U.S. only ranked number 30 this year on the report, down five spots from the 2012 report. Save the Children CEO Carolyn Miles told CBSNews.com she was shocked to find that out that the U.S. did so poorly.
“We do not do as well on many of those as the Scandinavian countries,” Miles admitted.

Results of a CDC-funded study entitled “A Clinical Analysis of Gelatin Allergy and Determination of its Causal Relationship to the Previous Administration of Gelatin-Containing Acellular Pertussis Vaccine Combined with Diphtheria and Tetanus Toxoids” concludes

Results of a CDC-funded study entitled “A Clinical Analysis of Gelatin Allergy and Determination of its Causal Relationship to the Previous Administration of Gelatin-Containing Acellular Pertussis Vaccine Combined with Diphtheria and Tetanus Toxoids” concludes:
“Most anaphylactic reactions and some urticarial reactions to gelatin-containing measles, mumps and rubella monovalent vaccines are associated with IgE-mediated gelatin allergy. DTaP immunization histories suggest that the gelatin-containing DTaP vaccine may have a causal relationship to the development of this gelatin allergy.”
Study: https://www.ncbi.nlm.nih.gov/pubmed/9949325
A clinical analysis of gelatin allergy and determination of its causal relationship to the previous administration of gelatin-containing acellular pertussis vaccine combined with diphtheria and tetanus toxoids.
RESULTS:
The 366 reported patients were categorized as follows: 34 with anaphylaxis, 76 with urticaria, 215 with nonurticarial generalized eruption, and 41 with local reactions only. In 206 patients from whom serum was available, IgE antibodies to gelatin were detected in 25 of 27 (93%) with anaphylaxis, 27 of 48 (56%) with urticaria, and 8 of 90 (9%) with a generalized eruption. None of a group of 41 patients with only local reactions at the injected site and none of a control group of 29 subjects with no adverse reaction had such antibodies. Among 202 patients for whom prior vaccine information was available, all had received DTaP vaccines. Among those for whom the prior DTaP vaccine could be determined to contain gelatin or be free of gelatin, 155 of 158 (98%) subjects had received gelatin-containing DTaP vaccines. This rate is higher than would be expected on the basis of the market share of gelatin-containing (vs gelatin-free) DTaP vaccines (75%). Furthermore, before 1993, when a trivalent measles, mumps, and rubella vaccine (with the same 0.2% gelatin content as the monovalent vaccines) was used and administered before DTaP vaccination, no reports of anaphylaxis to the measles, mumps, and rubella vaccine were received.
CONCLUSION:
Most anaphylactic reactions and some urticarial reactions to gelatin-containing measles, mumps, and rubella monovalent vaccines are associated with IgE-mediated gelatin allergy. DTaP immunization histories suggest that the gelatin-containing DTaP vaccine may have a causal relationship to the development of this gelatin allergy.